Background Approximately 10% of patients with Covid-19 experience symptoms beyond 3–4
weeks. Patients call this “long Covid”. We sought to document such patients’ lived …

increasing attention has been given to the experiences of people with COVID-19 whose
symptoms persist for 4 or more weeks. According to the Office for National Statistics (ONS), an …

Background In the absence of research into therapies and care pathways for long COVID,
guidance based on ‘emerging experience’ is needed. Aim To provide a rapid expert guide for …

Persistent symptoms lasting longer than 3 weeks are thought to affect 10–20% of patients
following SARS-CoV-2 infection. No formal guidelines exist in the UK for treating patients with …

The SARS-CoV-2 pandemic in the UK has so far affected more than four million people, with
more than 450 000 admitted to hospital and 30% in-hospital mortality. 1 The UK’s health …

Introduction Long COVID, a new condition whose origins and natural history are not yet fully
established, currently affects 1.5 million people in the UK. Most do not have access to …

We write as a group of doctors affected by persisting symptoms of suspected or confirmed
covid-19. We aim to share our insights from both personal experience of the illness and our …

Since the first wave of COVID-19 in March 2020 the number of people living with post-COVID
syndrome has risen rapidly at global pace, however, questions still remain as to whether …

The prolonged illness experienced by many patients following acute SARS-CoV2 infection
has been termed ‘Long Covid’(LC) by the self-organized patient groups formed on platforms …

Orthostatic intolerance (OI), including postural orthostatic tachycardia syndrome (PoTS) and
orthostatic hypotension (OH), are often reported in long covid, but published studies are …